H-GLAWEWWRTVI-OH
Ref. 3D-PP43378
| 1mg | 248.00 € | ||
| 10mg | 292.00 € | ||
| 100mg | 481.00 € |
Product Information
- NH2-Gly-Leu-Ala-Trp-Glu-Trp-Trp-Arg-Thr-Val-Ile-OH
Peptide H-GLAWEWWRTVI-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-GLAWEWWRTVI-OH include the following: Targeted Abrogation of TGF-beta Signaling in DC Enhances Anti-Tumor Responses Against TGF-beta-Secreting Tumors T Hahn, ET Akporiaye - Journal of Immunotherapy, 2006 - journals.lww.comhttps://journals.lww.com/immunotherapy-journal/fulltext/2006/11000/Targeted_Abrogation_of_TGF___Signaling_in_DC.72.aspx Analysis of T Cell Responses to Listeria Monocytogenes Listeriolysin O in Healthy Adult Individuals J Hampl, S Mathur, W Liu, P Lauer - Journal of , 2006 - journals.lww.comhttps://journals.lww.com/immunotherapy-journal/fulltext/2006/11000/Analysis_of_T_Cell_Responses_to_Listeria.73.aspx Multi-Epitope CTL Responses Induced in Metastatic NSCLC Patients With EP-2101, A 10-Epitope Peptide Vaccine G Ishioka, M Qin, X Huang - Journal of , 2006 - journals.lww.comhttps://journals.lww.com/immunotherapy-journal/fulltext/2006/11000/multi_epitope_ctl_responses_induced_in_metastatic.74.aspx Montanide ISA 51 VG as adjuvant for human vaccines F Bonhoure, J Gaucheron - Journal of Immunotherapy, 2006 - journals.lww.comhttps://journals.lww.com/immunotherapy-journal/fulltext/2006/11000/Montanide_ISA_51_VG_as_Adjuvant_for_Human_Vaccines.71.aspx
Chemical properties
Technical inquiry about: 3D-PP43378 H-GLAWEWWRTVI-OH
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
